Company Filing History:
Years Active: 2006-2013
Title: The Innovative Contributions of Petr Lustig
Introduction
Petr Lustig is a notable inventor based in Pardubice, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of dabigatran, an important anticoagulant medication. With a total of four patents to his name, Lustig's work has had a considerable impact on drug development.
Latest Patents
Lustig's latest patents include a method for the preparation of dabigatran and its intermediates. This involves the synthesis of intermediates for the preparation of dabigatran of specific formulae, as well as detailed methods for their preparation. One of his key patents outlines a method for the manufacture of dabigatran, detailing the chemical reactions involved in converting starting materials into the final product. This innovative approach enhances the efficiency and effectiveness of dabigatran production.
Career Highlights
Throughout his career, Petr Lustig has worked with prominent companies in the pharmaceutical industry, including Zentiva K.s. and Zentiva, A.s. His expertise in chemical synthesis and drug formulation has positioned him as a valuable asset in the field of medicinal chemistry. Lustig's contributions have not only advanced the science of drug development but have also improved patient outcomes through more effective medications.
Collaborations
Lustig has collaborated with several professionals in his field, including Josef Jirman and Jindrich Richter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of his work.
Conclusion
Petr Lustig's innovative contributions to the pharmaceutical industry, particularly in the preparation of dabigatran, highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options for patients.